CRISPR Therapeutics CRSP Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's prepaid & other current?
- CRISPR Therapeutics (CRSP) reported prepaid & other current of $6.58M in Q1 2026.
- How has CRISPR Therapeutics's prepaid & other current changed year-over-year?
- CRISPR Therapeutics's prepaid & other current decreased by 46.6% year-over-year, from $12.33M to $6.58M.
- What is the long-term trend for CRISPR Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's prepaid & other current has grown at a -17.7% compound annual growth rate (CAGR), from $26.14M to $9.84M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.